《“癌症靶向治疗”特刊》社论
Editorial of the Special Issue "Targeted Therapies for Cancer".
作者信息
Pastorino Fabio, Brignole Chiara
机构信息
Laboratorio di Terapie Sperimentali in Oncologia, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
出版信息
Biomedicines. 2022 May 11;10(5):1114. doi: 10.3390/biomedicines10051114.
Abstract
Cancer, the second leading cause of death worldwide, continues to represent an impressive challenge for researchers and clinicians [...].
摘要
癌症是全球第二大致死原因，对研究人员和临床医生而言仍然是一项艰巨的挑战。
相似文献
1
Editorial of the Special Issue "Targeted Therapies for Cancer".《“癌症靶向治疗”特刊》社论
Biomedicines. 2022 May 11;10(5):1114. doi: 10.3390/biomedicines10051114.
2
Special Issue: Resistance to Targeted Therapies in Human Cancer.特刊：人类癌症中的靶向治疗耐药性
Biomedicines. 2023 Jan 31;11(2):414. doi: 10.3390/biomedicines11020414.
3
Editorial for the Special Issue-"Recent Advances of Novel Pharmaceutical Designs for Anti-Cancer Therapies".专刊编辑寄语——“新型抗癌疗法药物设计的最新进展”
Int J Mol Sci. 2023 May 5;24(9):8238. doi: 10.3390/ijms24098238.
4
Editorial for the Special Issue "New Strategies in Cancer Pharmacotherapy: Development of Hormonal Antineoplastic Drugs, Cytotoxic Drugs and Targeted Therapies".专刊编辑寄语：“癌症药物治疗的新策略：激素抗肿瘤药物、细胞毒性药物和靶向治疗的开发”。
Int J Mol Sci. 2020 Jun 8;21(11):4081. doi: 10.3390/ijms21114081.
5
The inaugural Qatar Critical Care Conference with its Qatar Medical Journal Special Issue - An important milestone.首届卡塔尔重症监护会议及其《卡塔尔医学杂志》特刊——一个重要的里程碑。
Qatar Med J. 2019 Nov 7;2019(2):1. doi: 10.5339/qmj.2019.qccc.1. eCollection 2019.
6
Towards defining biomarkers indicating resistances to targeted therapies.迈向定义指示对靶向治疗耐药性的生物标志物。
Biochim Biophys Acta. 2014 May;1844(5):909-16. doi: 10.1016/j.bbapap.2013.11.006. Epub 2013 Nov 20.
7
Pathogenesis, Infection Prevention and Treatment.发病机制、感染预防与治疗。
Pathogens. 2020 May 18;9(5):385. doi: 10.3390/pathogens9050385.
8
9
Editorial: Applications of Cognitive and Behavioral Therapy in Response to COVID-19.社论：认知行为疗法在应对2019冠状病毒病中的应用
Cogn Behav Pract. 2021 Nov;28(4):455-458. doi: 10.1016/j.cbpra.2021.09.001. Epub 2021 Sep 14.
本文引用的文献
1
Targeted Osmotic Lysis: A Novel Approach to Targeted Cancer Therapies.靶向渗透裂解：一种靶向癌症治疗的新方法。
Biomedicines. 2022 Apr 2;10(4):838. doi: 10.3390/biomedicines10040838.
2
The Pyrazolo[3,4-]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma.封装于抗GD2免疫脂质体中的吡唑并[3,4 -]嘧啶衍生物Si306用于神经母细胞瘤的治疗
Biomedicines. 2022 Mar 12;10(3):659. doi: 10.3390/biomedicines10030659.
3
Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma.探究替莫唑胺在胶质母细胞瘤药理及临床研究中的作用位点
Biomedicines. 2021 Dec 21;10(1):1. doi: 10.3390/biomedicines10010001.
4
RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy.RICTOR影响黑色素瘤的肿瘤发生及其对靶向治疗的抗性。
Biomedicines. 2021 Oct 19;9(10):1498. doi: 10.3390/biomedicines9101498.
5
Role of Lamin A/C as Candidate Biomarker of Aggressiveness and Tumorigenicity in Glioblastoma Multiforme.核纤层蛋白A/C作为多形性胶质母细胞瘤侵袭性和致瘤性候选生物标志物的作用
Biomedicines. 2021 Sep 28;9(10):1343. doi: 10.3390/biomedicines9101343.
6
RIOK2 Inhibitor NSC139021 Exerts Anti-Tumor Effects on Glioblastoma via Inducing Skp2-Mediated Cell Cycle Arrest and Apoptosis.RIOK2抑制剂NSC139021通过诱导Skp2介导的细胞周期阻滞和凋亡对胶质母细胞瘤发挥抗肿瘤作用。
Biomedicines. 2021 Sep 17;9(9):1244. doi: 10.3390/biomedicines9091244.
7
Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo.靶向抑制抗炎调节因子Nrf2可导致乳腺癌在体内外生长迟缓。
Biomedicines. 2021 Aug 30;9(9):1119. doi: 10.3390/biomedicines9091119.
8
Targeting ErbB3 Receptor in Cancer with Inhibitory Antibodies from Llama.利用来自羊驼的抑制性抗体靶向癌症中的表皮生长因子受体3（ErbB3）
Biomedicines. 2021 Aug 28;9(9):1106. doi: 10.3390/biomedicines9091106.
9
Targeted Toxins for the Treatment of Prostate Cancer.用于治疗前列腺癌的靶向毒素
Biomedicines. 2021 Aug 9;9(8):986. doi: 10.3390/biomedicines9080986.
10
Advances and Limitations of Antibody Drug Conjugates for Cancer.癌症抗体药物偶联物的进展与局限
Biomedicines. 2021 Jul 23;9(8):872. doi: 10.3390/biomedicines9080872.
Zotero 插件